First Patient Enrolled in Stage 2 of Pivotal Study of SetPoint Medical's Pioneering Technology for the Treatment of Rheumatoid Arthritis

Source :: Business Wire. October 10, 2022
Publication Year :: 2022
Abstract: Results From RESET-RA Study Will Support FDA Submission for Approval of This Promising Treatment Approach for RA VALENCIA, Calif. -- SetPoint Medical, a clinical-stage healthcare company dedicated to patients with [...]

Subjects :: Rheumatoid factor -- Technology application
Antirheumatic agents -- Technology application
Arthritis -- Drug therapy
Drug approval -- Technology application
Technology application
Business
Business, international

Tools